Effects of Auricular Therapy in the treatment of Premenstrual Syndrome

INTERVENTION: E02.190.204 Experimental group: 30 women with symptoms of premenstrual syndrome will receive auriculotherapy once a week for 8 weeks and will be followed for 13 weeks. Placebo group: 30 women with symptoms of premenstrual syndrome will receive auriculotherapy at unrelated points once a week for 8 weeks and will be followed for 13 weeks CONDITION: C23.550.568.968 Premenstrual syndrome ; C23.550.568.968 PRIMARY OUTCOME: Improvement of the symptoms of premenstrual syndrome in at least 3 of the 14 symptoms listed by the PSST (Premenstrual Syndrome Screenning Tool) questionnaire. Data collected one week before the intervention, the fifth week, the week following the intervention (9th week) and a 4 week follow‐up (13th week) SECONDARY OUTCOME: Improvement in pain intensity (measured using the Nordic Symptom Questionnaire), anxiety (measured using the Beck Anxiety Inventory) and quality of life (measured using the WHOQoL‐Bref questionnaire). intervention, in the week after the intervention (week 9) and a follow‐up of 4 weeks (week 13) INCLUSION CRITERIA: WWomen aged 18‐35 years; sedentary; university students enrolled regularly at the Federal University of Paraná; and who have Premenstrual Syndrome (mild to moderate) or Pre‐Menstrual Dysphoric Disorder according to the criteria listed in the PSST (Premenstrual Syndrome Screening Tool)